Secular trends of endoscopic sleeve gastroplasty: analysis of the MBSAQIP database - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Trends Over Time in Endoscopic Sleeve Gastroplasty: Insights from the MBSAQIP Database Analysis

  • By

  • Benjamin M. Moy

  • Rolando Barajas

  • Chloe M. Savino

  • Allison R. Schulman

  • July 7, 2026

Share

  • 1

    The obesity epidemic affects nearly 4 in 10 adults in the U.S., with bariatric surgery being underutilized by eligible patients.

  • 2

    Endoscopic sleeve gastroplasty (ESG) is a safe and effective treatment for obesity, particularly for patients who are poor surgical candidates.

  • 3

    The number of ESG procedures increased by 50.5% from 2020 to 2023, indicating growing adoption of this treatment.

  • 4

    The mean BMI of patients undergoing ESG rose from 37.8 to 40.8 kg/m2 between 2020 and 2023, reflecting worsening obesity trends.

  • 5

    Despite increased BMI and comorbidities, the incidence of 30-day post-procedural adverse events remained statistically unchanged during the study.

Original Source(s)

Related Content